Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2026)

Legend Biotech (LEGN) has 7 years of Asset Utilization Ratio data on file, last reported at 0.68 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 54.29% year-over-year to 0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.68 (up 54.29% YoY) and the FY2025 annual result came in at 0.6, up 69.56% from the prior year.
• Asset Utilization Ratio grew to 0.68 in Q1 2026, from 0.6 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 45.22 in Q3 2024 to a low of 0.08 in Q1 2023.
• A 5-year average of 12.9 and a median of 0.51 in 2025 frame the typical range for Asset Utilization Ratio.
• The widest YoY moves for Asset Utilization Ratio: up 54004.99% in 2024, down 99.15% in 2024.
• Tracing LEGN's Asset Utilization Ratio over 5 years: stood at 0.12 in 2022, then jumped by 36951.55% to 43.21 in 2023, then tumbled by 99.15% to 0.37 in 2024, then jumped by 62.07% to 0.6 in 2025, then gained by 14.57% to 0.68 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.68 (Q1 2026), 0.6 (Q4 2025), and 0.53 (Q3 2025), per Business Quant data.